Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H22N4O6S |
| Molecular Weight | 446.477 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COCC(=O)NC1=CC(SC2=CC=CC=C2)=CC=C1N=C(NC(=O)OC)NC(=O)OC
InChI
InChIKey=HMCCXLBXIJMERM-UHFFFAOYSA-N
InChI=1S/C20H22N4O6S/c1-28-12-17(25)21-16-11-14(31-13-7-5-4-6-8-13)9-10-15(16)22-18(23-19(26)29-2)24-20(27)30-3/h4-11H,12H2,1-3H3,(H,21,25)(H2,22,23,24,26,27)
| Molecular Formula | C20H22N4O6S |
| Molecular Weight | 446.477 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | DRONTAL Approved UseDRONTAL Plus (praziquantel/pyrantel pamoate/febantel) TASTE TABS Broad Spectrum Chewable Anthelmintic Tablets are indicated for the removal of Tapeworms (Dipylidium caninum, Taenia pisiformis, Echinococcus granulosus, and removal and control of Echinococcus multilocularis) and for removal of Hookworms (Ancylostoma caninum, Uncinaria stenocephala), Ascarids (Toxocara canis, Toxascaris leonina) and Whipworms (Trichuris vulpis) in dogs. Launch Date2006 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synergistic effect of febantel and pyrantel embonate in elimination of Giardia in a gerbil model. | 2009-08 |
|
| Treatment of naturally occurring, asymptomatic Giardia sp. in dogs with Drontal Plus flavour tablets. | 2009-08 |
|
| Efficacy of Drontal Flavour Plus (50 mg praziquantel, 144 mg pyrantel embonate, 150 mg febantel per tablet) against Giardia sp in naturally infected dogs. | 2008-10 |
Patents
Sample Use Guides
Weight 0.9 to 1.8 kg (2 to 4 pounds): Dose is one-half tablet No.1 (22.7 milligrams praziquantel, 22.7 milligrams pyrantel base, and 113.4 milligrams febantel); Weight 2.3 to 3.2 kg (5 to 7 pounds): Dose is one tablet No.1; Weight 3.6 to 5.4 kg (8 to 12 pounds): Dose is one and one-half tablet No.1; Weight 5.9 to 8.2 kg (13 to 18 pounds): Dose is two tablets No.1; Weight 8.6 to 11.4 kg (19 to 25 pounds): Dose is two and one-half tablets No.1; Weight 11.8 to 13.6 kg (26 to 30 pounds): Dose is one tablet No.2 (68 milligrams praziquantel, 68 milligrams pyrantel base, and 340.2 milligrams febantel); Weight 14.1 to 20.0 kg (31 to 44 pounds): Dose is one and one-half tablets No.2; Weight 20.4 to 27.2 kg (45 to 60 pounds): Dose is two tablet No.2 and one tablet No. 3 (136 milligrams praziquantel, 136 milligrams pyrantel base, and 680.4 milligrams febantel); Weight 27.7 to 40.9 kg (61 to 90 pounds): Dose is one and one-half tablets No. 3; Weight 41.3 to 54.5 kg (91 to 120 pounds): Dose is two tablets No. 3.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:14:14 GMT 2025
by
admin
on
Mon Mar 31 18:14:14 GMT 2025
|
| Record UNII |
S75C401OS1
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 520.903D
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
||
|
CFR |
21 CFR 520.903B
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
||
|
CFR |
21 CFR 520.903
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
||
|
WHO-VATC |
QP52AC05
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
||
|
CFR |
21 CFR 520.903A
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
||
|
CFR |
21 CFR 520.1872
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
||
|
CFR |
21 CFR 520.903E
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
||
|
WHO-VATC |
QP52AC55
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C65625
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
S75C401OS1
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
1269356
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
58306-30-2
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
C017309
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
261-205-0
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
SUB07518MIG
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
DB11409
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
4385
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
100000081766
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
S75C401OS1
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
m5251
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL1080983
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
135449328
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
DTXSID6046898
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | |||
|
24805
Created by
admin on Mon Mar 31 18:14:14 GMT 2025 , Edited by admin on Mon Mar 31 18:14:14 GMT 2025
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
IMPURITY -> PARENT | |||
|
|
IMPURITY -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |